Non-invasive prenatal testing (NIPT) is a modern genetic screening method that allows the detection of chromosomal abnormalities in the fetus at early stages of pregnancy without any risk to the mother or the unborn child. Unlike invasive procedures such as amniocentesis or chorionic villus sampling, NIPT is performed using a maternal blood sample, making it a safe and highly accurate diagnostic tool.
What conditions can NIPT detect?
- Down syndrome (trisomy 21). One of the most common chromosomal abnormalities, associated with developmental delay and intellectual disability.
- Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13). These conditions are linked to severe congenital malformations and are often incompatible with long-term survival.
- Sex chromosome abnormalities. Detection of changes involving X and Y chromosomes, including Turner syndrome (XO), Klinefelter syndrome (XXY), and other sex chromosome disorders.
- Microdeletion syndromes. Some tests can identify rare chromosomal deletions, such as DiGeorge syndrome.
- Fetal sex determination. Possible as early as the 9th week of pregnancy.
How is non-invasive prenatal testing performed?
- Blood sample collection. A venous blood sample is taken from the pregnant woman, usually after 9–10 weeks of gestation. Maternal blood contains fragments of fetal DNA (cell-free fetal DNA) that are analyzed.
- Genetic analysis. High-precision sequencing technologies are used to analyze fetal DNA for chromosomal abnormalities.
- Results. Within 7–10 days, the patient receives a report indicating the probability of specific chromosomal abnormalities. If an increased risk is detected, additional diagnostic testing may be recommended.
Advantages of non-invasive prenatal testing
- Safety. NIPT poses no risk to the fetus, as it does not involve invasive procedures.
- High accuracy. The detection rate for Down syndrome reaches up to 99.9%.
- Early testing. The test can be performed from the 9th week of pregnancy.
- Minimal stress for the expectant mother. No anesthesia or prolonged medical observation is required.
- Fetal sex determination. An additional benefit for parents who wish to know the baby’s sex early.
When is NIPT recommended?
- For women over 35 years of age, as the risk of chromosomal abnormalities increases with maternal age.
- In cases of abnormal biochemical screening results indicating elevated risk.
- If there is a family history of genetic disorders.
- When previous children had chromosomal abnormalities.
- For parents seeking to reduce the need for invasive diagnostic procedures.
Limitations of NIPT
- NIPT does not fully replace invasive diagnostic procedures such as amniocentesis or chorionic villus sampling when serious genetic disorders are suspected.
- The test detects only the most common chromosomal abnormalities and not all possible genetic conditions.
- False-positive or false-negative results are possible, although they are rare.
Advantages of undergoing NIPT in Belarus
In Belarus, non-invasive prenatal testing is available in leading medical centers equipped with advanced molecular diagnostic technologies. High testing accuracy combined with professional genetic counseling allows pregnant women to receive reliable results without health risks. The availability of the service and short turnaround times make Belarus an attractive destination for prenatal genetic screening.
